Conditioning Agent
GALLOYL S-TEPIDAMORPHUS GEMMATUS OLIGOPEPTIDE-1 SP
Safety score · 0–100
Fine
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A novel cosmetic peptide ingredient produced by conjugating gallic acid to a synthetic peptide derived from the Tepidamorphus gemmatus organism, used for skin conditioning and protection.
Galloyl s-Tepidamorphus Gemmatus Oligopeptide-1 SP is the reaction product of Gallic Acid and s-Tepidamorphus Gemmatus Oligopeptide-1 SP, combining the antioxidant properties of gallic acid with the bioactivity of the oligopeptide. The ingredient is not listed in EU Annex II or III under Regulation 1223/2009. The galloylation (attachment of galloyl groups) is a common modification in plant biochemistry and is generally regarded as safe. As a relatively novel cosmetic ingredient, comprehensive long-term safety data are still accumulating, which accounts for the moderate safety score.
Function
Skin benefits
- Gallic acid moiety provides antioxidant properties that help protect skin from oxidative stress
- Oligopeptide component supports skin conditioning and has potential anti-aging effects
Known concerns
- Novel ingredient with less extensive historical safety data than established cosmetic compounds
- Gallic acid may cause mild irritation in individuals with sensitive skin at high concentrations
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related conditioning agents
Check your shelf
Find GALLOYL S-TEPIDAMORPHUS GEMMATUS OLIGOPEPTIDE-1 SP in your products.
Scan any cosmetic product with LuxSense to see if it contains GALLOYL S-TEPIDAMORPHUS GEMMATUS OLIGOPEPTIDE-1 SP and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.